These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8495272)

  • 1. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases.
    Arnold MM; McKenna F
    Br J Rheumatol; 1993 May; 32(5):437-8. PubMed ID: 8495272
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAIDs questionable as first-line therapy for rheumatic conditions in the elderly.
    Salach RH; Calabrese LH
    J Am Osteopath Assoc; 1994 Sep; 94(9):714, 766. PubMed ID: 7995734
    [No Abstract]   [Full Text] [Related]  

  • 4. Misoprostol and gastrointestinal complications in patients taking nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
    Wendel TD
    Ann Intern Med; 1996 May; 124(10):926; author reply 927. PubMed ID: 8610927
    [No Abstract]   [Full Text] [Related]  

  • 5. Misoprostol and gastrointestinal complications in patients taking nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
    Madhok R; McEntegart A; Maiden N
    Ann Intern Med; 1996 May; 124(10):926; author reply 927. PubMed ID: 8610926
    [No Abstract]   [Full Text] [Related]  

  • 6. Misoprostol and gastrointestinal complications in patients taking nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
    Hammer HF
    Ann Intern Med; 1996 May; 124(10):927. PubMed ID: 8610929
    [No Abstract]   [Full Text] [Related]  

  • 7. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
    [No Abstract]   [Full Text] [Related]  

  • 8. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases.
    Janssen M; Dijkmans BA; van der Sluys FA; van der Wielen JG; Havenga K; Vandenbroucke JP; Lamers CB; Zwinderman AH; Cats A
    Br J Rheumatol; 1992 Nov; 31(11):747-52. PubMed ID: 1450796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs.
    Collins AJ; Du Toit JA
    Br J Rheumatol; 1987 Aug; 26(4):295-8. PubMed ID: 3496934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol and gastrointestinal complications in patients taking nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
    Grossman CM
    Ann Intern Med; 1996 May; 124(10):926-7. PubMed ID: 8610928
    [No Abstract]   [Full Text] [Related]  

  • 11. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 12. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.
    Silverstein FE; Graham DY; Senior JR; Davies HW; Struthers BJ; Bittman RM; Geis GS
    Ann Intern Med; 1995 Aug; 123(4):241-9. PubMed ID: 7611589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory efficacy versus gastrointestinal safety: a dilemma resolved? Introduction.
    Bach GL
    Scand J Rheumatol Suppl; 1992; 96():5-6. PubMed ID: 1439625
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side effects of antirheumatic therapy on the gastrointestinal tract].
    Voigt J; Kaesberger W; Grün M
    Z Rheumatol; 1987; 46 Suppl 1():76-82. PubMed ID: 3326365
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the occurrence of gastrointestinal side-effects of tenoxicam and other nonsteroidal antirheumatic agents in patients with rheumatoid arthritis].
    Vlak T; Jajić I; Bilić A
    Reumatizam; 1996; 43(1):1-9. PubMed ID: 8966374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse effects of non-steroidal antirheumatic drugs with special reference to the gastrointestinal tract].
    Hackenthal E
    Z Rheumatol; 1987; 46 Suppl 1():83-8. PubMed ID: 3439373
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Laine L; Curtis SP; Cryer B; Kaur A; Cannon CP;
    Lancet; 2007 Feb; 369(9560):465-73. PubMed ID: 17292766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New standards in arthritis care. Proceedings of an ILAR symposium. Rio de Janeiro, Brazil, September 18, 1989.
    J Rheumatol Suppl; 1990 Feb; 20():1-53. PubMed ID: 2325050
    [No Abstract]   [Full Text] [Related]  

  • 19. Serious gastrointestinal events from low dose analgesic use.
    Peura DA
    J Rheumatol; 2004 May; 31(5):1009-10; author reply 1010-1. PubMed ID: 15124270
    [No Abstract]   [Full Text] [Related]  

  • 20. Serious gastrointestinal events from low dose analgesic use.
    Tarone RE; Lipworth L; McLaughlin JK
    J Rheumatol; 2004 May; 31(5):1008-9; author reply 1010-1. PubMed ID: 15124269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.